QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

DBVT

QT68DBV Technologies S.A.
NASDAQ·Healthcare·Biotechnology·FR
Latest market price
15.53
-0.75-4.61%
OverviewShort InterestFilings
DBVTQT68DBV Technologies S.A.·NASDAQ
OverviewShort InterestFilings
15.53-4.61%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-2.70
Insider Own-
Shs Outstand-
Perf Week-6.11%
Market Cap554.11MForward P/E-EPS next Y-0.41Insider Trans-Shs Float-Perf Month-16.10%
Enterprise Value331.01MPEG-EPS next Q-Inst Own-Short Float-Perf Quarter-20.15%
Income-66216027.00P/S0.00EPS this Y70.29%Inst Trans-Short Ratio-Perf Half Y-13.63%
Sales-P/B6.75EPS next Y48.38%ROA-62.96%Short Interest-Perf YTD-18.99%
Book/sh-P/C-EPS next 5Y-ROE-130.06%52W High26.19 -40.70%Perf Year63.99%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-74.64%52W Low8.50 82.71%Perf 3Y-
Dividend Est.-EV/EBITDA-2.09Sales past 3/5Y-Gross Margin0.00%Volatility4.57% 3.84%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-Oper. Margin0.00%ATR (14)1.03Perf 10Y-
Dividend Ex-Date-Quick Ratio4.76Sales Y/Y TTM-Profit Margin0.00%RSI (14)33.65Recom2.40
Dividend Gr. 3/5Y-Current Ratio4.76EPS Q/Q-SMA20-11.03%Beta1.14Target Price46.33
Payout0.00%Debt/Eq0.03Sales Q/Q-SMA50-18.62%Rel Volume1.36Prev Close16.28
Employees106LT Debt/Eq0.03Earnings-SMA200-11.79%Avg Volume234.89KPrice15.53
IPO DateOct 22, 2014Option/ShortYes / YesEPS/Sales Surpr.-Net Debt/EBITDA1.41Volume320,272Change-4.61%
Analyst Ratings
DateActionAnalystRatingTarget
Dec-18-25ReiteratedH.C. Wainwright$35 → $40
Dec-17-25ReiteratedCantor FitzgeraldOverweight$42 → $48
Dec-17-25ReiteratedGuggenheimBuy$35 → $51
Dec-15-25ReiteratedH.C. Wainwright$16 → $35
Dec-14-25InitiatedCantor FitzgeraldOverweight$42
Dec-03-25InitiatedGuggenheimBuy$35
May-05-25ReiteratedH.C. Wainwright$7.00 → $16
Mar-17-20DowngradeStifelBuy → Hold
Jan-09-20UpgradeStifelHold → Buy
Dec-20-18DowngradeJefferiesBuy → Hold
Latest News
Jun-17-26
Jun-17-2608:15PM
DBV Technologies (ENXTPA:DBV) Advances Peanut Patch With New Phase 3 Data And Infant TrialYahoo
Jun-16-26
Jun-16-2603:08PM
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday TradingYahoo
Jun-15-26
Jun-15-2611:59AM
DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock?Yahoo
Jun-12-26
Jun-12-2603:14PM
European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for WeekYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A0187
Gross Profit10-18-7
Selling, General and Administrative Excl. Other382824
Research and Development9611790
Other Operating Expense2320
Operating Income-148-147-121
Interest Expense200
Unusual Expense
———
Non-Operating Income (Expense)-240-3
Net Income Before Taxes-68-146-118
Income Taxes00-4
Consolidated Net Income-147-147-114
Net Income From Continuing Operations-147-147-114
Net Income-147-147-114
EPS (Recurring)-2.70-1.70-1.20
EPS (Basic, Before Extraordinaries)-2.70-1.70-1.20
EPS (Diluted)-2.70-1.70-1.20
EBITDA-102-139-111
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
85.41——
Gross Margin100.00——
Operating Margin-1,480.00——
Net Margin-1,470.00——
Shares Outstanding558696
Market Capitalization8541,649—
Operating Lease Expense
———
Insider Trading Volume
$19.06$17.89$16.73$15.57$14.40● Close Price0.00M3.87M7.74M11.61M15.48MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Mohideen PharisChief Medical OfficerJan 29 '26Sale4.865342,595144,995Feb 02 12:00 AM
BAKER BROS. ADVISORS LPDirectorJan 12 '26Option Exercise0.0052,310,136025,005,240Jan 14 12:00 AM
EPIC Bpifranceother: Member of 10% owner groupDec 18 '25Sale4.191,292,1035,413,9127,303,369Dec 19 12:00 AM
EPIC Bpifranceother: Member of 10% owner groupDec 17 '25Sale4.852,076,99010,070,2328,595,472Dec 19 12:00 AM
Mohideen PharisChief Medical OfficerNov 21 '25Sale2.771,6244,498101,529Nov 25 12:00 AM
Mohideen PharisChief Medical OfficerNov 20 '25Sale2.886,49618,708103,153Nov 25 12:00 AM
Mohideen PharisChief Medical OfficerJul 29 '25Sale2.224641,030109,649Jul 31 12:00 AM
Mohideen PharisChief Medical OfficerMay 22 '25Sale1.84397730110,113May 27 12:00 AM
Mohideen PharisChief Medical OfficerJan 30 '25Sale0.85600510110,510Jan 31 12:00 AM
Mohideen PharisChief Medical OfficerNov 25 '24Sale0.57565322111,110Nov 27 12:00 AM
Mohideen PharisChief Medical OfficerNov 22 '24Sale0.53342181111,675Nov 27 12:00 AM
Mohideen PharisChief Medical OfficerNov 21 '24Sale0.542,3501,269112,017Nov 25 12:00 AM
Mohideen PharisChief Medical OfficerJul 29 '24Sale0.981,7851,74979,367Jul 31 12:00 AM
Mohideen PharisChief Medical OfficerMay 24 '24Sale1.3666089881,152May 29 12:00 AM
Mohideen PharisChief Medical OfficerMay 22 '24Sale1.3838252781,812May 29 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR